ACC 2020: Rivaroxaban Plus Aspirin Reduce Cardiovascular Risk Regardless of Diabetes Status
Despite a small increase in bleeding risk, net clinical benefit was seen in both groups
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.